// App-Quantinova.ai

: Treatment Response and Impact Factor of Venetoclax Based Regimens in the Frontline Treatment of Newly Diagnosed Unfit Acute Myeloid Leukemia in the Real World of China

Researchers

Presenter

  • Guopan Yu

Principal Investigators

  • Zhao Yin

  • Dan Xu

  • Xuejie Jiang

  • Jieyu Ye

  • Yu Zhang

Medical Centers

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

  • Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved